Cytodyn Inc (CYDY)

[justdafactss]

ANVISA says no approval to treat patients in Brazil---

AUGUST 5
Last Monday (2/8), Anvisa approved the initiation of the clinical study to evaluate the safety and efficacy of the drug leronlimab and not the treatment of moderately ill patients with pneumonia caused by Covid-19.
https://www.gov.br/anvisa/pt-br/assuntos/noticias-anvisa/2021/anvisa-apresenta-um-panorama-das-vacinas-e-medicamentos-contra-a-covid-19

I send an e-mail few days ago to Dr NP telling him about my son and what to do, few minutes later Dr Kelly called me. So he told me it will not be possible to get leronlimab now since after being approve in Brazil they stopped for now EIND.